JOURNAL ARTICLE

Effects of adjunct treatment with intravenous Octagam on the course of severe COVID-19: results from a retrospective cohort study

Figen Esen, Perihan E Özcan, Günseli Orhun, Özlem Polat, İlkay Anaklı, Gülçin Alay, Verda Tuna, Emre Çeliksoy, Mehmet Kılıç, Mutlu Mercan, Tufan Tukek
Current Medical Research and Opinion 2020 November 25, : 1
33236646
Objectives: To evaluate the effect of adjunct treatment with Octagam, an intravenous immunoglobulin (IVIG) product, on clinical outcomes and biomarkers in critically ill COVID-19 patients. Methods: Data from a single center was analyzed retrospectively. Patients had received preliminary standard of intensive care (SIC) according to a local treatment algorithm, either alone or along with Octagam 5% at 30 g/day for 5 days. Both groups were compared regarding baseline characteristics, survival, and changes in inflammation markers. Imbalance in baseline APACHE II scores was addressed by propensity score matching. Otherwise, Kaplan-Meier and multiple logistic regression models were used. Results: Out of 93 patients, 51 had received Octagam and 42 had not. About 75% of patients were male and both groups had comparable body mass index and AB0 blood type distribution. Octagam-treated patients were younger (mean 65 ± 15 versus 71 ± 15 years, p = 0.066) and had slightly lower baseline disease scores (APACHE II: 20.6 versus 22.4, p = 0.281; SOFA: 5.0 versus 7.0, p = 0.006). Overall survival was 61% in the SIC + Octagam and 38% in the SIC only group (odds ratio: 2.2, 95% confidence interval: 0.9-5.4, p = 0.091 after controlling for baseline imbalances). Octagam significantly prolonged median survival time (68 versus 18 days, p = 0.014) and significantly reduced plasma levels of C-reactive protein (median change from baseline -71.5 versus -0.3 mg/L, p = 0.049). Conclusion: Clinically relevant benefits through adjunct Octagam treatment in COVID-19 need to be confirmed in a randomized, controlled trial.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Trending Papers

Remove bar
Read by QxMD icon Read
33236646
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"